300942 易瑞生物
按盤價 
10.980 -0.730 (-6.234%)
10.980 -0.730 (-6.234%) | 2025/06 - 中期 人民幣(K¥) | 與去年末期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 96,970 | -3.69% | 100,690 | 145,179 | 195,758 | 21,944 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 5,250 |
| 固定資產 | 501,685 | 38.16% | 363,111 | 57,102 | 83,986 | 52,628 |
| 在建工程 | 70,901 | -64.51% | 199,793 | 356,626 | 190,867 | 51,341 |
| 無形資產 | 38,272 | -2.47% | 39,243 | 41,393 | 42,400 | 42,600 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 10,097 | 272.17% | 2,713 | 18,370 | 95,026 | 81,113 |
| 717,926 | 1.75% | 705,550 | 618,669 | 608,036 | 254,876 | |
流動資產 | ||||||
| 貨幣資金 | 397,217 | 35.38% | 293,399 | 481,749 | 247,451 | 342,211 |
| 應收賬款 | 89,929 | -4.39% | 94,059 | 76,148 | 83,878 | 97,052 |
| 存貨 | 52,712 | 30.38% | 40,430 | 31,461 | 100,608 | 93,859 |
| 其他流動資產 | 162,372 | -49.84% | 323,728 | 148,312 | 242,482 | 364,522 |
| 702,228 | -6.57% | 751,616 | 737,670 | 674,419 | 897,644 | |
流動負債 | ||||||
| 短期借款 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付票據 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付帳款 | 57,880 | -1.50% | 58,762 | 77,352 | 65,107 | 55,658 |
| 其他流動負債 | 51,595 | -44.64% | 93,195 | 59,575 | 134,676 | 100,968 |
| 109,476 | -27.96% | 151,958 | 136,927 | 199,784 | 156,626 | |
| 流動資產淨值 | 592,753 | -1.15% | 599,658 | 600,743 | 474,636 | 741,018 |
| 資產總額減流動負債 | 1,310,679 | 0.42% | 1,305,208 | 1,219,412 | 1,082,672 | 995,894 |
非流動負債 | ||||||
| 長期借款 | 163,941 | 0.44% | 163,218 | 100,329 | 56,320 | 0 |
| 應付債券 | 273,806 | 4.04% | 263,169 | 245,452 | 0 | 0 |
| 其他非流動負債 | 7,511 | -12.45% | 8,579 | 24,903 | 61,651 | 49,314 |
| 445,259 | 2.37% | 434,966 | 370,684 | 117,971 | 49,314 | |
總權益 | ||||||
| 實收股本 | 401,318 | 0.00% | 401,317 | 400,860 | 400,860 | 400,860 |
| 儲備項目 | 463,075 | -0.99% | 467,689 | 448,134 | 564,031 | 543,903 |
| 股東權益 | 864,393 | -0.53% | 869,005 | 848,994 | 964,891 | 944,763 |
| 非控股權益 | 1,028 | -16.90% | 1,237 | (266) | (190) | 1,817 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 09/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
